Physician

James Francesconi, MD

According to 2025 Medicare claims, James Francesconi, MD (NPI: 1326209800) practices neurology in the Midland, TX market, with the plurality of this provider's patient population coming from Midland, TX. This provider's primary affiliated billing organization is ATTIGO INFUSION INC (NPI: 1891339644; TIN: 84-3505937) and primary practice location at 79705-5457.

Francesconi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 298 traditional Medicare patients, billed 20,841 HCPCS/CPT codes, and received $392,496 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,352 prescription claims across 288 beneficiaries totaling $712,190 in drug costs, led by Nuplazid (Pimavanserin Tartrate). Open Payments data shows 198 records totaling $3,978. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $108,790 to $392,496. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,343 to $712,190. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$519K$1.0M2015 Medicare payment: $108,790 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $111,550 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $68,774 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $92,501 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $106,602 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $77,096 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $146,347 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,038,092 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $891,717 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $392,496 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154341,197$108,790
20164591,305$111,550
2017338777$68,774
20183811,001$92,501
20194161,052$106,602
2020333763$77,096
2021305,252$146,347
202213631,501$1,038,092
202324142,933$891,717
202429820,841$392,496

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$559K$1.1M2015 Drug cost: $1,343 (USD; Tot_Drug_Cst)2017 Drug cost: $4,092 (USD; Tot_Drug_Cst)2018 Drug cost: $41,140 (USD; Tot_Drug_Cst)2019 Drug cost: $139,374 (USD; Tot_Drug_Cst)2020 Drug cost: $226,839 (USD; Tot_Drug_Cst)2021 Drug cost: $104,265 (USD; Tot_Drug_Cst)2022 Drug cost: $1,117,604 (USD; Tot_Drug_Cst)2023 Drug cost: $225,060 (USD; Tot_Drug_Cst)2024 Drug cost: $712,190 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R13$1,343
2016N/RN/RN/R
20171967$4,092
201875392$41,140
2019130970$139,374
20201501,161$226,839
202182280$104,265
202273350$1,117,604
2023181942$225,060
20242881,352$712,190

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more129129$151
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more89114$121
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more8798$85
J1306Injection, inclisiran, 1 mg329,372$9
96372Injection of drug or substance under skin or into muscle5173$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NuplazidPimavanserin Tartrate22840$151,295
CopaxoneGlatiramer Acetate13364$74,599
Nurtec OdtRimegepant Sulfate441,232$63,912
UbrelvyUbrogepant17461$24,216
Emgality PenGalcanezumab-Gnlm341,012$23,170

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.198$3,978ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Francesconi, MD?

Tedicare shows public-source Medicare data for James Francesconi, MD (NPI 1326209800), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Francesconi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Francesconi, MD?

James Francesconi, MD is linked to ATTIGO INFUSION INC (billing NPI 1891339644) in the available physician profile data.

Does James Francesconi, MD have Open Payments data?

James Francesconi, MD has 198 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.